Digestive System Irritable Bowel Syndrome

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Irritable Bowel Syndrome Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Irritable Bowel Syndrome Projects
--Alizyme plc
--AGI Therapeutics plc
--Bristol-Myers Squibb Company
--Avera Pharmaceuticals, Inc.
--Forest Laboratories Inc
--Dynogen Pharmaceuticals, Inc.
--Giaconda Limited
--Gastrotech Pharma A/S
--Menarini Group
--GlaxoSmithKline plc
--Neurocrine Biosciences Inc
--Microbia
--Pharmos Corporation
--Ocera Therapeutics, Inc.
--Rottapharm SpA
--Roche Holdings Ltd
--Solvay S.A.
--Salix Pharmaceuticals Ltd
--Tioga Pharmaceuticals Incorporated
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Irritable Bowel Syndrome Projects
--Arachnova Limited
--Antibe Therapeutics Inc.
--Callisto Pharmaceuticals Inc
--ArQule Inc
--Kemin Industries, Inc.
--Eisai Co Ltd
--N-Gene Research Laboratories, Inc.
--Lexicon Pharmaceuticals, Inc
--Rottapharm SpA
--Pharmos Corporation
--SK Bio-Pharmaceuticals
--Sanofi-Aventis
--Symphony Icon, Inc.
--Solvay S.A.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View